• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

音频审查作为阿尔茨海默病研究中认知评估质量保证和控制的一项措施:来自日本试验就绪队列研究的经验

Audio review as a measure of quality assurance and control of cognitive assessments in Alzheimer's disease studies: An experience from Japanese Trial-Ready Cohort Study.

作者信息

Sato Kenichiro, Ihara Ryoko, Niimi Yoshiki, Suzuki Kazushi, Iwata Atsushi, Iwatsubo Takeshi

机构信息

Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan.

出版信息

J Alzheimers Dis Rep. 2025 Jun 9;9:25424823251349188. doi: 10.1177/25424823251349188. eCollection 2025 Jan-Dec.

DOI:10.1177/25424823251349188
PMID:40496840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12150165/
Abstract

BACKGROUND

Clinical trials targeting preclinical Alzheimer's disease (AD) require accurate cognitive assessments to detect subtle changes over time. Audio review of assessment sessions has been proposed as a quality assurance (QA) and control (QC) measure, yet evidence regarding its effectiveness remains limited.

OBJECTIVE

We aim to investigate how audio review contributes to the QA/QC process.

METHODS

In the Japanese Trial-Ready Cohort (J-TRC) onsite study, 194 Preclinical Alzheimer's Cognitive Composite (PACC) sessions were audio-recorded and independently reviewed. Examiners were certified psychometrists who had undergone pre-training. Audio reviewers issued "queries" for scoring deviations warranting score amendments and "comments" for procedural deviations or recommended improvements. Mixed-effects models analyzed associations between the number of queries/comments and (1) cumulative PACC examination experience and (2) cumulative received feedback for individual examiners.

RESULTS

Of 194 reviewed sessions, 63.4% contained at least one query, and 84.5% included one or more comments. A higher cumulative number of PACC sessions by each examiner was associated with fewer queries and smaller score changes over time. Notably, the cumulative number of feedback reports was significantly associated with a lower number of comments, suggesting targeted feedback helped refine examiners' testing manner. However, cumulative feedback was not clearly linked to the frequency of scoring deviations (queries).

CONCLUSIONS

These findings indicate that audio review can serve as an effective QA/QC measure by reducing non-adherence to assessment standards.

摘要

背景

针对临床前阿尔茨海默病(AD)的临床试验需要准确的认知评估,以检测随时间推移的细微变化。评估环节的音频审查已被提议作为一种质量保证(QA)和质量控制(QC)措施,但关于其有效性的证据仍然有限。

目的

我们旨在研究音频审查如何促进QA/QC流程。

方法

在日本试验就绪队列(J-TRC)现场研究中,对194次临床前阿尔茨海默病认知综合测试(PACC)环节进行了音频录制并独立审查。审查人员是经过预培训的认证心理测量师。音频审查员针对需要修改分数的评分偏差发出“询问”,针对程序偏差或建议改进发出“评论”。混合效应模型分析了询问/评论数量与(1)PACC检查累计经验和(2)单个审查员收到的累计反馈之间的关联。

结果

在194次审查的环节中,63.4%至少包含一个询问,84.5%包含一个或多个评论。每位审查员的PACC环节累计数量越多,询问数量越少,且随着时间推移分数变化越小。值得注意的是,反馈报告的累计数量与评论数量显著减少相关,表明有针对性的反馈有助于改进审查员的测试方式。然而,累计反馈与评分偏差(询问)的频率没有明显关联。

结论

这些发现表明,音频审查可通过减少对评估标准的不遵守作为一种有效的QA/QC措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108f/12150165/406d7b62f242/10.1177_25424823251349188-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108f/12150165/a89573e9de53/10.1177_25424823251349188-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108f/12150165/7113ddcdbb0e/10.1177_25424823251349188-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108f/12150165/406d7b62f242/10.1177_25424823251349188-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108f/12150165/a89573e9de53/10.1177_25424823251349188-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108f/12150165/7113ddcdbb0e/10.1177_25424823251349188-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108f/12150165/406d7b62f242/10.1177_25424823251349188-fig3.jpg

相似文献

1
Audio review as a measure of quality assurance and control of cognitive assessments in Alzheimer's disease studies: An experience from Japanese Trial-Ready Cohort Study.音频审查作为阿尔茨海默病研究中认知评估质量保证和控制的一项措施:来自日本试验就绪队列研究的经验
J Alzheimers Dis Rep. 2025 Jun 9;9:25424823251349188. doi: 10.1177/25424823251349188. eCollection 2025 Jan-Dec.
2
Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.临床前阿尔茨海默病认知综合指标(PACC)对临床前阿尔茨海默病淀粉样β负荷的敏感性。
J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600. doi: 10.1080/13803395.2019.1593949. Epub 2019 Mar 29.
3
The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.用于临床前和前驱期阿尔茨海默病的试验准备队列(TRC-PAD):前 3 年的经验。
J Prev Alzheimers Dis. 2020;7(4):234-241. doi: 10.14283/jpad.2020.47.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.以目标为导向的认知康复治疗早期阿尔茨海默病及相关痴呆: GREAT RCT 研究。
Health Technol Assess. 2019 Mar;23(10):1-242. doi: 10.3310/hta23100.
6
Usability of a Web-Based Registry for Preclinical Alzheimer's Disease: Implications from a Cross-Sectional Online Survey.基于网络的阿尔茨海默病临床前登记系统的可用性:来自横断面在线调查的启示。
J Prev Alzheimers Dis. 2024;11(3):661-671. doi: 10.14283/jpad.2024.48.
7
Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.在早期临床试验中,临床前阿尔茨海默病认知复合指标(PACC)、PACC5 和神经心理状态重复电池(RBANS)对淀粉样蛋白状态的敏感性-Atabecestat 2b/3 期
J Prev Alzheimers Dis. 2022;9(2):255-261. doi: 10.14283/jpad.2022.17.
8
Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials.临床前阿尔茨海默病认知综合量表(PACC)的最佳加权,以提高其作为阿尔茨海默病临床试验结局指标的性能。
Int J Stat Med Res. 2023 Feb 15;12:90-96. doi: 10.6000/1929-6029.2023.12.12. Epub 2023 Sep 7.
9
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.AHEAD 3-45 研究:阿尔茨海默病预防试验设计。
Alzheimers Dement. 2023 Apr;19(4):1227-1233. doi: 10.1002/alz.12748. Epub 2022 Aug 15.
10
Pilot Medical Certification飞行员医学认证

本文引用的文献

1
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan.公众对日本阿尔茨海默病抗淀粉样蛋白治疗的医疗保健准备情况的看法。
Alzheimers Res Ther. 2024 Oct 3;16(1):205. doi: 10.1186/s13195-024-01568-8.
2
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly.联合检测血浆 Aβ和 p-tau217 可提高对非痴呆老年人脑淀粉样蛋白的检测效果。
Alzheimers Res Ther. 2024 May 23;16(1):115. doi: 10.1186/s13195-024-01469-w.
3
Usability of a Web-Based Registry for Preclinical Alzheimer's Disease: Implications from a Cross-Sectional Online Survey.
基于网络的阿尔茨海默病临床前登记系统的可用性:来自横断面在线调查的启示。
J Prev Alzheimers Dis. 2024;11(3):661-671. doi: 10.14283/jpad.2024.48.
4
Trial of Solanezumab in Preclinical Alzheimer's Disease.在临床前阿尔茨海默病中进行的 Solanezumab 试验。
N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17.
5
Lecanemab: Appropriate Use Recommendations.仑卡奈单抗:合理使用建议。
J Prev Alzheimers Dis. 2023;10(3):362-377. doi: 10.14283/jpad.2023.30.
6
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.AHEAD 3-45 研究:阿尔茨海默病预防试验设计。
Alzheimers Dement. 2023 Apr;19(4):1227-1233. doi: 10.1002/alz.12748. Epub 2022 Aug 15.
7
The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview.临床试验准备队列用于临床前/前驱阿尔茨海默病(TRC-PAD)项目:概述。
J Prev Alzheimers Dis. 2020;7(4):208-212. doi: 10.14283/jpad.2020.45.
8
Data quality assurance and control in cognitive research: Lessons learned from the PREDICT-HD study.认知研究中的数据质量保证和控制:来自 PREDICT-HD 研究的经验教训。
Int J Methods Psychiatr Res. 2017 Sep;26(3). doi: 10.1002/mpr.1534. Epub 2017 Feb 17.
9
The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.临床前阿尔茨海默病认知综合评分:测量与淀粉样蛋白相关的衰退。
JAMA Neurol. 2014 Aug;71(8):961-70. doi: 10.1001/jamaneurol.2014.803.
10
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.阿尔茨海默病病理生理过程的追踪:动态生物标志物的更新假设模型。
Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0.